SYRINX Bioanalytics is a CRO focusing on the bioanalysis and immunogenicity testing of biological drugs, vaccines, biomarkers and small molecules providing GLP compliant laboratory services using state-of-the-art immunological, chromatographic and cell based methods.
Over 20 years of experience in GLP – involvement in numerous drug development projects from preclinical to globally marketed products in e.g. Europe, Northern America and Japan.
Immunogenicity testing
Following latest guidelines and white papers SYRINX is providing novel immunogenicity assay designs and methods for immunogenicity testing. Try out and see flash animation of various screening assay designs.
Novel techniques
SYRINX is offering to its customers a large variety of novel ligand binding, cell based, kinetic rate and small molecule assays. State-of-the-art instruments such as
-
Gyrolab xP Workstation
-
Biacore T200 GxP
-
MSD Sector Imager 2400 (Meso Scale)
-
AutoDELFIA automatic immunoassay system
-
Envision Xcite and VictorV multilabel readers
- Winspectral/Wizard Beta & Gammacounters
- Agilent GC-MS/HPLC
are enabling Gyros CD microlaboratory,
surface plasmon resonance (SPR), electrochemiluminescence (ECL), DELFIA, ELISA, AlphaScreen/AlphaLISA, RIA and GC-MS/HPLC techniques.
News and events
SYRINX attended 6th Annual International Partnering Conference BIO-Europe Spring 2012 on 19-21 March 2012 in Amsterdam, Netherlands.
SYRINX will attend the PerkinElmer Owners Group Europe -symposium on 12-13 June 2012 in London, UK.